Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
F Pericle, M Giovarelli, M P Colombo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1995
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory
M Giovarelli, P Musiani, A Modesti, et al.
Natural Immunity
|
March 1, 1994
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes
P Musiani, A Modesti, M Brunetti, et al.
The Journal of Pathology
|
January 1, 1997
Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene
S Scarpa, A Giuffrida, C Palumbo, et al.
Cancer Research
|
April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
L Cifaldi, E Quaglino, E Di Carlo, et al.
International Journal of Cancer
|
August 5, 2000
Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response
R Meazza, P L Lollini, P Nanni, et al.
International Journal of Cancer
|
September 9, 1993
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene
P L Lollini, M C Bosco, F Cavallo, et al.
Cancer Research
|
February 10, 2000
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice
K Boggio, E Di Carlo, S Rovero, et al.
Gene Therapy
|
June 13, 2001
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination
S M Pupa, A M Invernizzi, S Forti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
February 28, 2002
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice
F Gavallo, E Di Carlo, E Quaglin, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
F Pericle, M Giovarelli, M P Colombo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1995
Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory
M Giovarelli, P Musiani, A Modesti, et al.
Natural Immunity
|
March 1, 1994
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes
P Musiani, A Modesti, M Brunetti, et al.
The Journal of Pathology
|
January 1, 1997
Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene
S Scarpa, A Giuffrida, C Palumbo, et al.
Cancer Research
|
April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
L Cifaldi, E Quaglino, E Di Carlo, et al.
International Journal of Cancer
|
August 5, 2000
Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response
R Meazza, P L Lollini, P Nanni, et al.
International Journal of Cancer
|
September 9, 1993
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene
P L Lollini, M C Bosco, F Cavallo, et al.
Cancer Research
|
February 10, 2000
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice
K Boggio, E Di Carlo, S Rovero, et al.
Gene Therapy
|
June 13, 2001
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination
S M Pupa, A M Invernizzi, S Forti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
February 28, 2002
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice
F Gavallo, E Di Carlo, E Quaglin, et al.
Page
of 16